- 抑制劑
- 化合物庫
- 抗體
- 生物試劑
- 新產品
- 聯(lián)系我們
PF-543 hydrochloride 是一種新型Sphingosine kinase 1 (SphK1, SK1) (鞘氨醇激酶)抑制劑,Ki為3.6 nM。PF-543 hydrochloride 可誘導細胞凋亡、壞死和自噬。
PF-543 hydrochloride Chemical Structure
CAS: 1706522-79-3
相關產品 | Opaganib (ABC294640) SKI II SKI-V | 點擊展開 |
---|---|---|
相關化合物庫 | 激酶抑制劑庫 FDA藥物庫 天然產物庫 已知活性藥物庫-I 高選擇性抑制劑庫 | 點擊展開 |
細胞系 | 實驗類型 | 給藥濃度 | 孵育時間 | 活性描述 | 文獻信息 |
---|---|---|---|---|---|
human PAMSC cells | Function assay | 100 nM | 24 h | Decrease of SK1 expression in human PAMSC cells at 100 nM after 24 hrs by Western blot analysis | 24396570 |
HEK293 | Function assay | 10 uM | 16 hrs | Induction of SK1 degradation in HEK293 cells at 10 uM after 16 hrs by western blotting analysis in presence of proteasome inhibitor MG132 | 26780304 |
Sf21 cells | Function assay | 90 mins | Inhibition of His6 tagged human SphK1 expressed in Sf21 cells using FITC-sphingosine as substrate preincubated for 90 mins prior substrate addition by Caliper assay, Ki=4.3 nM | 25516793 | |
PC3 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human PC3 cells after 72 hrs by MTS assay, GI50=19μM. | 26780304 | |
MDA1483 | Function assay | 30 mins | Inhibition of SPHK1 in human MDA1483 cells using C17-sphingosine as substrate assessed as reduction in C17-S1P formation preincubated for 30 mins with substrate measured after 15 mins by LC-MS analysis, IC50=0.0008μM. | 28231433 | |
Sf9 | Function assay | 15 mins | Inhibition of human C-terminal His6-tagged SPHK1 expressed in fall armyworm sf9 cells assessed as reduction in ADP formation using sphingosine as substrate preincubated for 15 mins followed by substrate addition after 1 hr by transcreener-based fluorescen, IC50=0.002μM. | 28231433 | |
Sf9 | Function assay | 1 hr | Inhibition of human C-terminal His6-tagged SPHK1 expressed in fall armyworm sf9 cells assessed as reduction in S1P formation using sphingosine as substrate after 1 hr by FITC-based caliper assay, IC50=0.0027μM. | 28231433 | |
Sf21 | Function assay | 1 hr | Inhibition of recombinant human C-terminal His-tagged SPHK1 expressed in fall armyworm sf21 cells using sphingosine as substrate after 1 hr by FITC-based caliper assay, Ki=0.0036μM. | 28406646 | |
Sf21 | Function assay | 1 hr | Inhibition of recombinant C-terminal His6-tagged human SphK1 expressed in baculovirus infected sf21 cells using FITC-sphingosine as substrate after 1 hr in presence of ATP by microfluidic capillary electrophoresis mobility shift assay, IC50=0.0027μM. | 28408190 | |
Sf21 | Function assay | 1 hr | Inhibition of human recombinant C-terminal His6 tagged SphK2 expressed in baculovirus infected sf21 cells using FITC-sphingosine as substrate after 1 hr in presence of ATP by microfluidic capillary electrophoresis mobility shift assay, IC50=0.36μM. | 28408190 | |
HEK293 | Function assay | 30 mins | Inhibition of GFP-tagged SK1 (unknown origin) expressed in HEK293 cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis, IC50=0.028μM. | 30889352 | |
Sf9 cells | Function assay | Inhibition of human recombinant SphK1 expressed in Sf9 cells assessed as radiolabeled products using 5 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting | 25643074 | ||
Sf21 | Function assay | Inhibition of human C-terminal His6-tagged SphK1 expressed in baculovirus infected Sf21 insect cells, Ki=0.0036μM. | 28822281 | ||
點擊查看更多細胞系數據 |
產品描述 | PF-543 hydrochloride 是一種新型Sphingosine kinase 1 (SphK1, SK1) (鞘氨醇激酶)抑制劑,Ki為3.6 nM。PF-543 hydrochloride 可誘導細胞凋亡、壞死和自噬。 | ||||
---|---|---|---|---|---|
特性 | 迄今為止SPHK1最有效的抑制劑。 | ||||
靶點 |
|
分子量 | 502.07 | 分子式 | C27H32ClNO4S |
CAS號 | 1706522-79-3 | SDF | Download PF-543 hydrochloride SDF |
Smiles | CC1=CC(=CC(=C1)OCC2=CC=C(C=C2)CN3CCCC3CO)CS(=O)(=O)C4=CC=CC=C4.Cl | ||
儲存條件(自收到貨起) | |||
體外溶解度 |
DMSO : 100 mg/mL ( (199.17 mM) ;DMSO吸濕會降低化合物溶解度,請使用新開封DMSO) Ethanol : 100 mg/mL (199.17 mM) Water : Insoluble |
摩爾濃度計算器 |
體內溶解度 現(xiàn)配現(xiàn)用,請按從左到右的順序依次添加,澄清后再加入下一溶劑 |
動物體內配方計算器 |
動物體內配方計算器(澄清溶液)
第一步:請輸入基本實驗信息(考慮到實驗過程中的損耗,建議多配一只動物的藥量)
第二步:請輸入動物體內配方組成(配方適用于不溶于水的藥物;不同批次藥物配方比例不同,請聯(lián)系Selleck為您提供正確的澄清溶液配方)
計算結果:
工作液濃度: mg/ml;
DMSO母液配制方法: mg 藥物溶于μL DMSO溶液(母液濃度mg/mL,注:如該濃度超過該批次藥物DMSO溶解度,請先聯(lián)系Selleck);
體內配方配制方法:取μL DMSO母液,加入μL PEG300,混勻澄清后加入μL Tween 80,混勻澄清后加入μL ddH2O,混勻澄清。
體內配方配制方法:取μL DMSO母液,加入μL Corn oil,混勻澄清。
注意:1. 首先保證母液是澄清的;
2.一定要按照順序依次將溶劑加入,進行下一步操作之前必須保證上一步操作得到的是澄清的溶液,可采用渦旋、超聲或水浴加熱等物理方法助溶。
在訂購、運輸、儲存和使用我們的產品的任何階段,您遇到的任何問題,均可以通過撥打我們的熱線電話400-668-6834,或者技術支持郵箱tech@selleck.cn,直接聯(lián)系到我們。我們會在24小時內盡快聯(lián)系您。
如果有其他問題,請給我們留言。
* 必填項